Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01677065 · ClinicalTrials.gov registry record

A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers

A clinical trial of Healthy, sponsored by Pfizer.

Completed
Registry status
14
Enrollment target
1
Study location

NCT01677065 is a study of Healthy that has completed, run by Pfizer. The registered enrollment target is 14 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01677065, a study of Healthy, has completed, sponsored by Pfizer.

COMPLETED
Registry status
14 participants
Enrollment target
1
Study location

Study Summary

To determine whether the bioavailability of the controlled-release test formulation is at least as high as that for the commercial reference drug.

Conditions Studied

Healthy

Interventions

  • DRUG Oxycodone controlled-release test formulation
  • DRUG Immediate-release reference drug

Study Locations (1)

Connecticut

  • Pfizer Investigational Site - New Haven

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2012-09
Est. Completion 2012-10

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01677065

The ClinicalTrials.gov registry entry for NCT01677065 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Oxycodone controlled-release test formulation is the first listed.

NCT01677065 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT01677065 about?

NCT01677065 is a clinical study titled "A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers". To determine whether the bioavailability of the controlled-release test formulation is at least as high as that for the commercial reference drug.

What is the current status of trial NCT01677065?

This trial is currently completed. The enrollment target is 14 participants. The study started on 2012-09. Estimated completion is 2012-10.

What conditions does trial NCT01677065 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01677065?

The interventions under investigation include: Oxycodone controlled-release test formulation (DRUG), Immediate-release reference drug (DRUG).

Who is sponsoring clinical trial NCT01677065?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01677065 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.